NGGT has initiated Phase I/II clinical trials in the U.S. and China to evaluate the safety and efficacy of NGGT002 for the treatment of Phenylketonuria WALNUT CREEK, Calif., Nov. 11, 2024 ...

Considering taking supplements to treat phenylketonuria pku? Below is a list of common natural remedies used to treat or reduce the symptoms of phenylketonuria pku. Follow the links to read common ...

The firm, which plans to use the ticker symbol "MAZE" on the Nasdaq, develops drugs designed to mimic the protective effects ...

Sepiapterin is PTC's treatment for phenylketonuria, a disease in which the body can't break down the amino acid phenylalanine. The Food and Drug Administration is currently reviewing the data ...

Synthetic biology specialist Synlogic will start phase 3 testing of a drug for rare metabolic disorder phenylketonuria ... At the moment the main treatment strategy is to restrict phe in the ...

The company has plans to further evaluate this candidate for the treatment of chronic kidney disease and phenylketonuria, with Phase I trial results expected in the second half of 2025.

today announced the full readout and compelling results from the clinical trial evaluating PKU GOLIKE as a protein substitute for the treatment of phenylketonuria (PKU) in patients during ...

a protein substitute tailored for the treatment of phenylketonuria (PKU) in patients undergoing extended fasting periods. The trial exhibited convincing results indicating that PKU GOLIKE ...